Studies and clinical testing directed to obtain the market authorization in Spain or abroad do not infringe the patent rights. This includes preparing, obtaining and using of the relevant active ingredient.
Recent tweets
ZBM recognised in the IAM European Patent Office (EPO) Patent rankings 2022 zbm-patents.eu/en/zbm-recogni… pic.twitter.com/3pQ8sdAsl9